2型糖尿病薬の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Type 2 Diabetes Medication Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16823 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、123ページ • 納品方法：Eメール • 産業分類：医薬品・治療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、2型糖尿病薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。2型糖尿病薬の種類別市場規模（ビグアナイド、スルホニル尿素、チアゾリジンジオン、アルファグルコシダーゼ阻害剤、DPP-4阻害剤、GLP-1受容体アゴニスト、SGLT-2阻害剤、インスリン）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、Merck、Johnson & Johnson、Novartis、Eli Lilly、Novo Nordisk、Pfizer、Bristol-Myers Squibb、Boehringer Ingelheim、Sanofi、Bayer AG、Astellas Pharma、Takeda、Glenmark、Daiichi Sankyo、Sun pharma、Biocon ・地域別グローバル市場分析 2015年-2020年 ・2型糖尿病薬の北米市場（アメリカ、カナダ、メキシコ） ・2型糖尿病薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・2型糖尿病薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・2型糖尿病薬の南米市場（ブラジル、アルゼンチン） ・2型糖尿病薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ビグアナイド、スルホニル尿素、チアゾリジンジオン、アルファグルコシダーゼ阻害剤、DPP-4阻害剤、GLP-1受容体アゴニスト、SGLT-2阻害剤、インスリン ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Type 2 Diabetes Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Type 2 Diabetes Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Type 2 Diabetes Medication market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Type 2 Diabetes Medication market has been segmented into:
Biguanides
Sulphonylureas
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Insulins

By Application, Type 2 Diabetes Medication has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Type 2 Diabetes Medication market presented in the report. This section sheds light on the sales growth of different regional and country-level Type 2 Diabetes Medication markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Type 2 Diabetes Medication market.

The report offers in-depth assessment of the growth and other aspects of the Type 2 Diabetes Medication market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Type 2 Diabetes Medication Market Share Analysis
Type 2 Diabetes Medication competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Type 2 Diabetes Medication sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Type 2 Diabetes Medication sales, revenue and market share for each player covered in this report.

The major players covered in Type 2 Diabetes Medication are:
AstraZeneca
Merck
Johnson & Johnson
Novartis
Eli Lilly
Novo Nordisk
Pfizer
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Bayer AG
Astellas Pharma
Takeda
Glenmark
Daiichi Sankyo
Sun pharma
Biocon

レポート目次

---

Table of Contents

1 Type 2 Diabetes Medication Market Overview
1.1 Product Overview and Scope of Type 2 Diabetes Medication
1.2 Classification of Type 2 Diabetes Medication by Type
1.2.1 Global Type 2 Diabetes Medication Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Type 2 Diabetes Medication Revenue Market Share by Type in 2019
1.2.3 Biguanides
1.2.4 Sulphonylureas
1.2.5 Thiazolidinediones
1.2.6 Alpha-glucosidase Inhibitors
1.2.7 DPP-4 Inhibitors
1.2.8 GLP-1 Receptor Agonists
1.2.9 SGLT-2 Inhibitors
1.2.10 Insulins
1.3 Global Type 2 Diabetes Medication Market by Application
1.3.1 Overview: Global Type 2 Diabetes Medication Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Type 2 Diabetes Medication Market by Regions
1.4.1 Global Type 2 Diabetes Medication Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Type 2 Diabetes Medication (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Type 2 Diabetes Medication Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Type 2 Diabetes Medication Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Type 2 Diabetes Medication Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Type 2 Diabetes Medication Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Type 2 Diabetes Medication Status and Prospect (2015-2025)
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novo Nordisk
2.6.1 Novo Nordisk Details
2.6.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novo Nordisk SWOT Analysis
2.6.4 Novo Nordisk Product and Services
2.6.5 Novo Nordisk Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bristol-Myers Squibb SWOT Analysis
2.8.4 Bristol-Myers Squibb Product and Services
2.8.5 Bristol-Myers Squibb Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanofi SWOT Analysis
2.10.4 Sanofi Product and Services
2.10.5 Sanofi Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bayer AG
2.11.1 Bayer AG Details
2.11.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bayer AG SWOT Analysis
2.11.4 Bayer AG Product and Services
2.11.5 Bayer AG Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.12 Astellas Pharma
2.12.1 Astellas Pharma Details
2.12.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Astellas Pharma SWOT Analysis
2.12.4 Astellas Pharma Product and Services
2.12.5 Astellas Pharma Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Takeda SWOT Analysis
2.13.4 Takeda Product and Services
2.13.5 Takeda Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.14 Glenmark
2.14.1 Glenmark Details
2.14.2 Glenmark Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Glenmark SWOT Analysis
2.14.4 Glenmark Product and Services
2.14.5 Glenmark Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.15 Daiichi Sankyo
2.15.1 Daiichi Sankyo Details
2.15.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Daiichi Sankyo SWOT Analysis
2.15.4 Daiichi Sankyo Product and Services
2.15.5 Daiichi Sankyo Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.16 Sun pharma
2.16.1 Sun pharma Details
2.16.2 Sun pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Sun pharma SWOT Analysis
2.16.4 Sun pharma Product and Services
2.16.5 Sun pharma Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
2.17 Biocon
2.17.1 Biocon Details
2.17.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Biocon SWOT Analysis
2.17.4 Biocon Product and Services
2.17.5 Biocon Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Type 2 Diabetes Medication Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Type 2 Diabetes Medication Players Market Share
3.2.2 Top 10 Type 2 Diabetes Medication Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Type 2 Diabetes Medication Revenue and Market Share by Regions
4.2 North America Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
4.3 Europe Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
4.5 South America Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
5 North America Type 2 Diabetes Medication Revenue by Countries
5.1 North America Type 2 Diabetes Medication Revenue by Countries (2015-2020)
5.2 USA Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
5.3 Canada Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
5.4 Mexico Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
6 Europe Type 2 Diabetes Medication Revenue by Countries
6.1 Europe Type 2 Diabetes Medication Revenue by Countries (2015-2020)
6.2 Germany Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
6.3 UK Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
6.4 France Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
6.5 Russia Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
6.6 Italy Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Type 2 Diabetes Medication Revenue by Countries
7.1 Asia-Pacific Type 2 Diabetes Medication Revenue by Countries (2015-2020)
7.2 China Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
7.3 Japan Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
7.4 Korea Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
7.5 India Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
8 South America Type 2 Diabetes Medication Revenue by Countries
8.1 South America Type 2 Diabetes Medication Revenue by Countries (2015-2020)
8.2 Brazil Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
8.3 Argentina Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Type 2 Diabetes Medication by Countries
9.1 Middle East & Africa Type 2 Diabetes Medication Revenue by Countries (2015-2020)
9.2 Saudi Arabia Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
9.3 UAE Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
9.4 Egypt Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
9.5 South Africa Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Type 2 Diabetes Medication Revenue and Market Share by Type (2015-2020)
10.2 Global Type 2 Diabetes Medication Market Forecast by Type (2019-2024)
10.3 Biguanides Revenue Growth Rate (2015-2025)
10.4 Sulphonylureas Revenue Growth Rate (2015-2025)
10.5 Thiazolidinediones Revenue Growth Rate (2015-2025)
10.6 Alpha-glucosidase Inhibitors Revenue Growth Rate (2015-2025)
10.7 DPP-4 Inhibitors Revenue Growth Rate (2015-2025)
10.8 GLP-1 Receptor Agonists Revenue Growth Rate (2015-2025)
10.9 SGLT-2 Inhibitors Revenue Growth Rate (2015-2025)
10.10 Insulins Revenue Growth Rate (2015-2025)
11 Global Type 2 Diabetes Medication Market Segment by Application
11.1 Global Type 2 Diabetes Medication Revenue Market Share by Application (2015-2020)
11.2 Type 2 Diabetes Medication Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Type 2 Diabetes Medication Market Size Forecast (2021-2025)
12.1 Global Type 2 Diabetes Medication Market Size Forecast (2021-2025)
12.2 Global Type 2 Diabetes Medication Market Forecast by Regions (2021-2025)
12.3 North America Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
12.4 Europe Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
12.6 South America Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Type 2 Diabetes Medication Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Type 2 Diabetes Medication by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Type 2 Diabetes Medication Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Type 2 Diabetes Medication Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AstraZeneca Corporate Information, Location and Competitors
Table 6. AstraZeneca Type 2 Diabetes Medication Major Business
Table 7. AstraZeneca Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 8. AstraZeneca SWOT Analysis
Table 9. AstraZeneca Type 2 Diabetes Medication Product and Solutions
Table 10. AstraZeneca Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Merck Corporate Information, Location and Competitors
Table 12. Merck Type 2 Diabetes Medication Major Business
Table 13. Merck Type 2 Diabetes Medication Total Revenue (USD Million) (2018-2019)
Table 14. Merck SWOT Analysis
Table 15. Merck Type 2 Diabetes Medication Product and Solutions
Table 16. Merck Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Type 2 Diabetes Medication Major Business
Table 19. Johnson & Johnson Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Type 2 Diabetes Medication Product and Solutions
Table 22. Johnson & Johnson Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Type 2 Diabetes Medication Major Business
Table 25. Novartis Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Type 2 Diabetes Medication Product and Solutions
Table 28. Novartis Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Eli Lilly Corporate Information, Location and Competitors
Table 30. Eli Lilly Type 2 Diabetes Medication Major Business
Table 31. Eli Lilly Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 32. Eli Lilly SWOT Analysis
Table 33. Eli Lilly Type 2 Diabetes Medication Product and Solutions
Table 34. Eli Lilly Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novo Nordisk Corporate Information, Location and Competitors
Table 36. Novo Nordisk Type 2 Diabetes Medication Major Business
Table 37. Novo Nordisk Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 38. Novo Nordisk SWOT Analysis
Table 39. Novo Nordisk Type 2 Diabetes Medication Product and Solutions
Table 40. Novo Nordisk Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pfizer Corporate Information, Location and Competitors
Table 42. Pfizer Type 2 Diabetes Medication Major Business
Table 43. Pfizer Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 44. Pfizer SWOT Analysis
Table 45. Pfizer Type 2 Diabetes Medication Product and Solutions
Table 46. Pfizer Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 48. Bristol-Myers Squibb Type 2 Diabetes Medication Major Business
Table 49. Bristol-Myers Squibb Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 50. Bristol-Myers Squibb SWOT Analysis
Table 51. Bristol-Myers Squibb Type 2 Diabetes Medication Product and Solutions
Table 52. Bristol-Myers Squibb Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 54. Boehringer Ingelheim Type 2 Diabetes Medication Major Business
Table 55. Boehringer Ingelheim Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 56. Boehringer Ingelheim SWOT Analysis
Table 57. Boehringer Ingelheim Type 2 Diabetes Medication Product and Solutions
Table 58. Boehringer Ingelheim Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sanofi Corporate Information, Location and Competitors
Table 60. Sanofi Type 2 Diabetes Medication Major Business
Table 61. Sanofi Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 62. Sanofi SWOT Analysis
Table 63. Sanofi Type 2 Diabetes Medication Product and Solutions
Table 64. Sanofi Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bayer AG Corporate Information, Location and Competitors
Table 66. Bayer AG Type 2 Diabetes Medication Major Business
Table 67. Bayer AG Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 68. Bayer AG SWOT Analysis
Table 69. Bayer AG Type 2 Diabetes Medication Product and Solutions
Table 70. Bayer AG Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Astellas Pharma Corporate Information, Location and Competitors
Table 72. Astellas Pharma Type 2 Diabetes Medication Major Business
Table 73. Astellas Pharma Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 74. Astellas Pharma SWOT Analysis
Table 75. Astellas Pharma Type 2 Diabetes Medication Product and Solutions
Table 76. Astellas Pharma Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Takeda Corporate Information, Location and Competitors
Table 78. Takeda Type 2 Diabetes Medication Major Business
Table 79. Takeda Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 80. Takeda SWOT Analysis
Table 81. Takeda Type 2 Diabetes Medication Product and Solutions
Table 82. Takeda Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Glenmark Corporate Information, Location and Competitors
Table 84. Glenmark Type 2 Diabetes Medication Major Business
Table 85. Glenmark Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 86. Glenmark SWOT Analysis
Table 87. Glenmark Type 2 Diabetes Medication Product and Solutions
Table 88. Glenmark Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Daiichi Sankyo Corporate Information, Location and Competitors
Table 90. Daiichi Sankyo Type 2 Diabetes Medication Major Business
Table 91. Daiichi Sankyo Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 92. Daiichi Sankyo SWOT Analysis
Table 93. Daiichi Sankyo Type 2 Diabetes Medication Product and Solutions
Table 94. Daiichi Sankyo Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Sun pharma Corporate Information, Location and Competitors
Table 96. Sun pharma Type 2 Diabetes Medication Major Business
Table 97. Sun pharma Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 98. Sun pharma SWOT Analysis
Table 99. Sun pharma Type 2 Diabetes Medication Product and Solutions
Table 100. Sun pharma Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Biocon Corporate Information, Location and Competitors
Table 102. Biocon Type 2 Diabetes Medication Major Business
Table 103. Biocon Type 2 Diabetes Medication Total Revenue (USD Million) (2017-2018)
Table 104. Biocon SWOT Analysis
Table 105. Biocon Type 2 Diabetes Medication Product and Solutions
Table 106. Biocon Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Type 2 Diabetes Medication Revenue (Million USD) by Players (2015-2020)
Table 108. Global Type 2 Diabetes Medication Revenue Share by Players (2015-2020)
Table 109. Global Type 2 Diabetes Medication Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Type 2 Diabetes Medication Revenue Market Share by Regions (2015-2020)
Table 111. North America Type 2 Diabetes Medication Revenue by Countries (2015-2020)
Table 112. North America Type 2 Diabetes Medication Revenue Market Share by Countries (2015-2020)
Table 113. Europe Type 2 Diabetes Medication Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Type 2 Diabetes Medication Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Type 2 Diabetes Medication Revenue by Countries (2015-2020)
Table 116. South America Type 2 Diabetes Medication Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Type 2 Diabetes Medication Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Type 2 Diabetes Medication Revenue Market Share by Countries (2015-2020)
Table 119. Global Type 2 Diabetes Medication Revenue (Million USD) by Type (2015-2020)
Table 120. Global Type 2 Diabetes Medication Revenue Share by Type (2015-2020)
Table 121. Global Type 2 Diabetes Medication Revenue Forecast by Type (2021-2025)
Table 122. Global Type 2 Diabetes Medication Revenue by Application (2015-2020)
Table 123. Global Type 2 Diabetes Medication Revenue Share by Application (2015-2020)
Table 124. Global Type 2 Diabetes Medication Revenue Forecast by Application (2021-2025)
Table 125. Global Type 2 Diabetes Medication Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Type 2 Diabetes Medication Picture
Figure 2. Global Type 2 Diabetes Medication Revenue Market Share by Type in 2019
Figure 3. Biguanides Picture
Figure 4. Sulphonylureas Picture
Figure 5. Thiazolidinediones Picture
Figure 6. Alpha-glucosidase Inhibitors Picture
Figure 7. DPP-4 Inhibitors Picture
Figure 8. GLP-1 Receptor Agonists Picture
Figure 9. SGLT-2 Inhibitors Picture
Figure 10. Insulins Picture
Figure 11. Type 2 Diabetes Medication Revenue Market Share by Application in 2019
Figure 12. Hospital Pharmacies Picture
Figure 13. Retail Pharmacies Picture
Figure 14. Online Pharmacies Picture
Figure 15. Global Type 2 Diabetes Medication Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Type 2 Diabetes Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Type 2 Diabetes Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Type 2 Diabetes Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Type 2 Diabetes Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Type 2 Diabetes Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Type 2 Diabetes Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Type 2 Diabetes Medication Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Type 2 Diabetes Medication Revenue Market Share in 2019
Figure 24. Global Top 10 Players Type 2 Diabetes Medication Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Type 2 Diabetes Medication Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Type 2 Diabetes Medication Revenue Market Share by Regions (2015-2020)
Figure 28. Global Type 2 Diabetes Medication Revenue Market Share by Regions in 2018
Figure 29. North America Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 30. Europe Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 32. South America Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 34. North America Type 2 Diabetes Medication Revenue Market Share by Countries (2015-2020)
Figure 35. North America Type 2 Diabetes Medication Revenue Market Share by Countries in 2019
Figure 36. USA Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 37. Canada Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 39. Europe Type 2 Diabetes Medication Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Type 2 Diabetes Medication Revenue Market Share by Countries in 2019
Figure 41. Germany Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 42. UK Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 43. France Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 44. Russia Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 45. Italy Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Type 2 Diabetes Medication Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Type 2 Diabetes Medication Revenue Market Share by Countries in 2019
Figure 48. China Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 49. Japan Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 50. Korea Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 51. India Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 53. South America Type 2 Diabetes Medication Revenue Market Share by Countries (2015-2020)
Figure 54. South America Type 2 Diabetes Medication Revenue Market Share by Countries in 2019
Figure 55. Brazil Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Type 2 Diabetes Medication Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Type 2 Diabetes Medication Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 60. UAE Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Type 2 Diabetes Medication Revenue and Growth Rate (2015-2020)
Figure 63. Global Type 2 Diabetes Medication Revenue Share by Type (2015-2020)
Figure 64. Global Type 2 Diabetes Medication Revenue Share by Type in 2019
Figure 65. Global Type 2 Diabetes Medication Market Share Forecast by Type (2021-2025)
Figure 66. Global Biguanides Revenue Growth Rate (2015-2020)
Figure 67. Global Sulphonylureas Revenue Growth Rate (2015-2020)
Figure 68. Global Thiazolidinediones Revenue Growth Rate (2015-2020)
Figure 69. Global Alpha-glucosidase Inhibitors Revenue Growth Rate (2015-2020)
Figure 70. Global DPP-4 Inhibitors Revenue Growth Rate (2015-2020)
Figure 71. Global GLP-1 Receptor Agonists Revenue Growth Rate (2015-2020)
Figure 72. Global SGLT-2 Inhibitors Revenue Growth Rate (2015-2020)
Figure 73. Global Insulins Revenue Growth Rate (2015-2020)
Figure 74. Global Type 2 Diabetes Medication Revenue Share by Application (2015-2020)
Figure 75. Global Type 2 Diabetes Medication Revenue Share by Application in 2019
Figure 76. Global Type 2 Diabetes Medication Market Share Forecast by Application (2021-2025)
Figure 77. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 78. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 79. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 80. Global Type 2 Diabetes Medication Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Type 2 Diabetes Medication Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Type 2 Diabetes Medication Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
Figure 84. Europe Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
Figure 86. South America Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Type 2 Diabetes Medication Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel

---